Branded Legacy Inc (OTCPK:BLEG) acquired MariJ Pharmaceuticals, Inc. on December 4, 2023. The acquisition is a combination of preferred series stock and cash. Presently, there are a total of 3,864,884 remaining Series D Preferred Shares outstanding. Among this total, 2,000,000 shares were initially issued for the acquisition of MariJ.

Branded Legacy Inc (OTCPK:BLEG) completed the acquisition of MariJ Pharmaceuticals, Inc. on December 4, 2023.